Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study

Monkeypox is caused by a DNA virus known as the monkeypox virus (MPXV) belonging to the <i>Orthopoxvirus</i> genus of the Poxviridae family. Monkeypox is a zoonotic disease where the primary significant hosts are rodents and non-human primates. There is an increasing global incidence wit...

Full description

Bibliographic Details
Main Authors: Gagan Preet, Emmanuel T. Oluwabusola, Bruce Forbes Milne, Rainer Ebel, Marcel Jaspars
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/22/14287
_version_ 1797465016120639488
author Gagan Preet
Emmanuel T. Oluwabusola
Bruce Forbes Milne
Rainer Ebel
Marcel Jaspars
author_facet Gagan Preet
Emmanuel T. Oluwabusola
Bruce Forbes Milne
Rainer Ebel
Marcel Jaspars
author_sort Gagan Preet
collection DOAJ
description Monkeypox is caused by a DNA virus known as the monkeypox virus (MPXV) belonging to the <i>Orthopoxvirus</i> genus of the Poxviridae family. Monkeypox is a zoonotic disease where the primary significant hosts are rodents and non-human primates. There is an increasing global incidence with a 2022 outbreak that has spread to Europe in the middle of the COVID-19 pandemic. The new outbreak has novel, previously undiscovered mutations and variants. Currently, the US Food and Drug Administration (FDA) approved poxvirus treatment involving the use of tecovirimat. However, there has otherwise been limited research interest in monkeypox. Mitoxantrone (MXN), an anthracycline derivative, an FDA-approved therapeutic for treating cancer and multiple sclerosis, was previously reported to exhibit antiviral activity against the vaccinia virus and monkeypox virus. In this study, virtual screening, molecular docking analysis, and pharmacophore ligand-based modelling were employed on anthracene structures <b>(1-13)</b> closely related to MXN to explore the potential repurposing of multiple compounds from the PubChem library. Four chemical structures <b>(2)</b>, <b>(7)</b>, <b>(10)</b> and <b>(12)</b> show a predicted high binding potential to suppress viral replication.
first_indexed 2024-03-09T18:16:27Z
format Article
id doaj.art-2d03b9eba9b64b349bca6d1c12428801
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T18:16:27Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-2d03b9eba9b64b349bca6d1c124288012023-11-24T08:41:41ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-11-0123221428710.3390/ijms232214287Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore StudyGagan Preet0Emmanuel T. Oluwabusola1Bruce Forbes Milne2Rainer Ebel3Marcel Jaspars4Marine Biodiscovery Centre, Department of Chemistry, University of Aberdeen, Aberdeen AB24 3UE, Scotland, UKMarine Biodiscovery Centre, Department of Chemistry, University of Aberdeen, Aberdeen AB24 3UE, Scotland, UKMarine Biodiscovery Centre, Department of Chemistry, University of Aberdeen, Aberdeen AB24 3UE, Scotland, UKMarine Biodiscovery Centre, Department of Chemistry, University of Aberdeen, Aberdeen AB24 3UE, Scotland, UKMarine Biodiscovery Centre, Department of Chemistry, University of Aberdeen, Aberdeen AB24 3UE, Scotland, UKMonkeypox is caused by a DNA virus known as the monkeypox virus (MPXV) belonging to the <i>Orthopoxvirus</i> genus of the Poxviridae family. Monkeypox is a zoonotic disease where the primary significant hosts are rodents and non-human primates. There is an increasing global incidence with a 2022 outbreak that has spread to Europe in the middle of the COVID-19 pandemic. The new outbreak has novel, previously undiscovered mutations and variants. Currently, the US Food and Drug Administration (FDA) approved poxvirus treatment involving the use of tecovirimat. However, there has otherwise been limited research interest in monkeypox. Mitoxantrone (MXN), an anthracycline derivative, an FDA-approved therapeutic for treating cancer and multiple sclerosis, was previously reported to exhibit antiviral activity against the vaccinia virus and monkeypox virus. In this study, virtual screening, molecular docking analysis, and pharmacophore ligand-based modelling were employed on anthracene structures <b>(1-13)</b> closely related to MXN to explore the potential repurposing of multiple compounds from the PubChem library. Four chemical structures <b>(2)</b>, <b>(7)</b>, <b>(10)</b> and <b>(12)</b> show a predicted high binding potential to suppress viral replication.https://www.mdpi.com/1422-0067/23/22/14287in silicomonkeypoxdrug repurposingepidemicpoxvirusespharmacophore
spellingShingle Gagan Preet
Emmanuel T. Oluwabusola
Bruce Forbes Milne
Rainer Ebel
Marcel Jaspars
Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study
International Journal of Molecular Sciences
in silico
monkeypox
drug repurposing
epidemic
poxviruses
pharmacophore
title Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study
title_full Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study
title_fullStr Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study
title_full_unstemmed Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study
title_short Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study
title_sort computational repurposing of mitoxantrone related structures against monkeypox virus a molecular docking and 3d pharmacophore study
topic in silico
monkeypox
drug repurposing
epidemic
poxviruses
pharmacophore
url https://www.mdpi.com/1422-0067/23/22/14287
work_keys_str_mv AT gaganpreet computationalrepurposingofmitoxantronerelatedstructuresagainstmonkeypoxvirusamoleculardockingand3dpharmacophorestudy
AT emmanueltoluwabusola computationalrepurposingofmitoxantronerelatedstructuresagainstmonkeypoxvirusamoleculardockingand3dpharmacophorestudy
AT bruceforbesmilne computationalrepurposingofmitoxantronerelatedstructuresagainstmonkeypoxvirusamoleculardockingand3dpharmacophorestudy
AT rainerebel computationalrepurposingofmitoxantronerelatedstructuresagainstmonkeypoxvirusamoleculardockingand3dpharmacophorestudy
AT marceljaspars computationalrepurposingofmitoxantronerelatedstructuresagainstmonkeypoxvirusamoleculardockingand3dpharmacophorestudy